ABC | Volume 113, Nº4, October 2019

Updated Updated Cardiovascular Prevention Guideline of the Brazilian Society Of Cardiology – 2019 Arq Bras Cardiol. 2019; 113(4):787-891 172. Razvodovsky YE. Contribution of alcohol to hypertension mortality in Russia. J Addict. 2014 Feb;2014:483910. 173. Intersalt Cooperative Research Group. “INTERSALT”: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassiumexcretion. BMJ. 1988;297(6644):319-28. 174. Lang T, Cambien F, Richard JL, Bingham A. Mortality in cerebrovascular diseases and alcoholism in France. Presse Med. 1987;16(28):1351-4. 175. FuchsFD,ChamblessLE,FolsomAR,EigenbrodtML,DuncanBB,GilbertA, et al. Association between alcoholic beverage consumption and incidence of coronary heart disease in whites and blacks: the Atherosclerosis Risk in Communities Study. Am J Epidemiol. 2004;160(5):466-74. 176. World Health Organization.(WHO). Global status report on alcohol and health. Geneva; 2014. 177. Rosito GA, Fuchs FD, Duncan BB. Dose-dependent biphasic effect of ethanol on 24 hours blood pressure in normotensive subjects. Am J Hypertens. 1999;12(2 Pt 1):236-40. 178. Mori, TA, Burke, V, Beilin, LJ, Puddey, IB. Randomized controlled intervention of the effects of alcohol on blood pressure in premenopausal women. Hypertension. 2015;66(3):517-23. 179. Zilkens RR, Burke V, Hodgson JM, BardenA, Beilin LJ, Puddey IB. Redwine and beer elevate blood pressure in normotensive men. Hypertension. 2005;45(5):874-9. 180. Xin X, He J, Frontini MG, Ogden LG, Motsamai OI, Whelton PK. Effects of alcohol reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension. 2001;38(5):1112-7. 181. Appel LJ, Brands MW, Daniels SR, Karanja N, Elmer PJ, Sacks FM, et al. Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association. Hypertension. 2006;47(2):296-308. 182. FormanJP,StampferMJ,CurhanGC.Dietand lifestyleriskfactorsassociated with incident hypertension in women. JAMA. 2009;302(4):401-11. 183. Tobias DK, Chen M, Manson JE, Ludwig DS, Willett W, Hu FB. Effect of low-fat diet interventions versus other diet interventions on long-term weight change in adults: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2015;3(12):968-79. 184. Whelton PK, Appel LJ, EspelandMA, ApplegateWB, EttingerWH Jr, Kostis JB,etal.Sodiumreductionandweight loss inthetreatmentofhypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative ResearchGroup. JAMA. 1998;279(11):839-46. 185. Stelmach-Mardas M, Walkowiak J. Dietary interventions and changes in cardio-metabolic parameters in metabolically healthy obese subjects: a systematic review with meta-analysis. Nutrients. 2016;8(8):pii:E455. 186. Semlitsch T, Jeitler K, Berghold A, Horvath K, PoschN, Poggenburg S, et al. Long-term effects of weight-reducing diets in people with hypertension. Cochrane Database Syst Rev. 2016 Mar 2;3:CD008274. 187. Mozaffarian D, Hao T, Rimm EB, Willett WC, Hu FB. Changes in diet and lifestyle and long-term weight gain in women and men. N Engl J Med. 2011;364(25):2392-404. 188. Stamler J. The INTERSALT Study: background, methods, findings, and implications. Am J Clin Nutr. 1997;65(2 Suppl):626S-42. 189. Oliveira GMM, Mendes M, Malachias MVB, Morais J, Moreira O Filho, Coelho AS, et al. 2017 Guidelines for Arterial HypertensionManagement in Primary Health Care in Portuguese Language Countries. Arq Bras Cardiol. 2017;109(5):389-96. 190. Rahimi K, Emdin CA, MacMahon S. The epidemiology of blood pressure and its worldwide management. Circ Res. 2015;116(6):925-36. 191. GBD.2013Mortality andCauses of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specificmortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385(9963):117-71. 192. Ribeiro AL, Duncan BB, Brant LC, Lotufo PA, Mill JG, Barreto SM. Cardiovascular Health in Brazil: trends and perspectives. Circulation. 2016;133(4):422-33. 193. Zanchetti A, Thomopoulos C, Parati G. Randomized controlled trials of blood pressure lowering in hypertension: a critical reappraisal. Circ Res. 2015;116(6):1058-73. 194. Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure lowering on outcome incidence in hypertension: 2. Effects at different baseline and achieved blood pressure levels--overview and meta-analyses of randomized trials. J Hypertens. 2014;32(12):2296-304. 195. Rapsomaniki E, Timmis A, George J, Pujades-Rodriguez M, Shah AD, Denaxas S, et al. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1.25 million people. Lancet. 2014;383(9932):1899-911. 196. Xie X, Atkins E, Lv J, Bennett A, Neal B, Ninomiya T, et al. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review andmeta-analysis. Lancet. 2016;387(10017):435-43. 197. SPRINT ResearchGroup,Wright JT Jr,Williamson JD,Whelton PK, Snyder JK, Sink KM, et al. A Randomized Trial of Intensive versus Standard Blood- Pressure Control. N Engl J Med. 2015;373(22):2103-16. 198. Dungan K, Craven TE, Soe K, Wright JT Jr, Basile J, Haley WE, et al. Influence of metabolic syndrome and race on the relationship between intensive blood pressure control and cardiovascular outcomes in the SPRINT cohort. Diabetes Obes Metab. 2018;20(3):629-37. 199. ACCORD Study Group, CushmanWC, Evans GW, Byington RP, Goff DC Jr, Grimm RH Jr, et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010;362(17):1575-85. 200. Vidal-Petiot E, Ford I, Greenlaw N, Ferrari R, Fox KM, Tardif JC, et al. Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study. Lancet. 2016;388(10056):2142-52. 201. Micha R, Penalvo JL, Cudhea F, Imamura F, Rehm CD, Mozaffarian D. Associationbetweendietaryfactorsandmortalityfromheartdisease,stroke, and type 2 diabetes in the United States. JAMA. 2017;317(9):912-24. 202. Iqbal R, Anand S, Ounpuu S, IslamS, Zhang X, Rangarajan S, et al. Dietary patterns and the risk of acutemyocardial infarction in 52 countries: results of the INTERHEART study. Circulation. 2008;118(19):1929-37. 203. Voutilainen S, Nurmi T, Mursu J, Rissanen TH. Carotenoids and cardiovascular health. Am J Clin Nutr. 2006;83(6):1265-71. 204. VivekananthanDP, PennMS, Sapp SK, Hsu A, Topol EJ. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet. 2003;361(9374):2017-23. 205. Ye Y, Li J, Yuan Z. Effect of antioxidant vitamin supplementation on cardiovascular outcomes: ameta-analysis of randomized controlled trials. PLoS One. 2013;8(2):e56803. 206. Maugeri A, Hruskova J, Jakubik J, Kunzova S, Sochor O, Barchitta M, et al. Dietary antioxidant intake decreases carotid intima media thickness in women but not in men: A cross-sectional assessment in the Kardiovize study. Free Radic Biol Med. 2019 Feb 1;131:274-81. 207. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA. 2007;297(8):842-57. 208. Blomhoff R. Dietary antioxidants and cardiovascular disease. Curr Opin Lipidol. 2005;16(1):47-54. 209. Sesso HD, Buring JE, Christen WG, Kurth T, Belanger C, MacFadyen J, et al. Vitamins E and C in the prevention of cardiovascular disease in 874